Stay updated on Tisagenlecleucel in HR B-ALL Clinical Trial
Sign up to get notified when there's something new on the Tisagenlecleucel in HR B-ALL Clinical Trial page.

Latest updates to the Tisagenlecleucel in HR B-ALL Clinical Trial page
- Check3 days agoChange DetectedRevision: v3.6.2 is displayed on the page, indicating a software release update. No study content or data appear to be altered by this change.SummaryDifference0.0%

- Check10 days agoChange DetectedThree update dates were added to the study record (2026-06-18, 2026-06-17, 2026-06), indicating recent revisions to the page without changing the trial's substantive information.SummaryDifference0.1%

- Check17 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', and new help/navigation sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study' were added. The label for Intervention/Treatment was normalized from 'Intervention / Treatment' and the revision tag updated from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check25 days agoChange DetectedThe page now shows an updated list of study locations with new sites in Indianapolis, IN (Indiana University) and Rome, Italy, and a reduced total of 43 locations.SummaryDifference0.8%

- Check46 days agoChange DetectedThe website version is updated from v3.5.3 to v3.5.4, indicating an under-the-hood update to the platform. No study text or data were changed on the page.SummaryDifference0.0%

- Check53 days agoChange DetectedA new citation has been added to Publications for an immunotherapy article by Davis et al., with full bibliographic details. This adds additional reference material for readers.SummaryDifference0.0%

Stay in the know with updates to Tisagenlecleucel in HR B-ALL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tisagenlecleucel in HR B-ALL Clinical Trial page.